Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
J Surg Oncol. 2020 Jun;121(8):1209-1217. doi: 10.1002/jso.25910. Epub 2020 Mar 20.
The aim was to evaluate long-term prognostic factors in hepatocellular carcinoma (HCC) patients who survived over 10 years after hepatectomy and compare prognostic factors between patients with recurrence who died and survived 10 years after initial hepatectomy.
We analyzed the HCC patients without recurrence over 10 years after hepatectomy (n = 35), those with recurrence who survived over 10 years (n = 48), and those who died within 10 years (n = 132).
The rate of recurrence was 16.3%, 10-year overall survival rate was 38.6%, and the 10-year recurrence-free survival (RFS) rate was 16.7%. Nonviral, solitary tumor, well differentiation, and without severe fibrosis were independent favorable factors for long-term RFS. High cholinesterase levels, small tumors and without portal vein invasion were independent favorable factors for long-term survival among patients with recurrence. Long-term survivors with recurrence showed significantly low early recurrence, extrahepatic recurrence, multiple intrahepatic recurrences.
Important factors for long-term prognoses in HCC patients were a solitary tumor, small tumors, and no advanced fibrosis. A treatment for nonviral hepatitis is needed to achieve long-term RFS. Even patients who relapse might survive long term if they have a late or solitary intrahepatic recurrence, nonsevere cirrhosis, and curative treatment at recurrence.
本研究旨在评估肝癌(HCC)患者行肝切除术后生存 10 年以上的长期预后因素,并比较复发后生存 10 年以上与 10 年内死亡患者的预后因素。
我们分析了肝切除术后 10 年以上无复发的 HCC 患者(n=35)、复发后生存 10 年以上的患者(n=48)和 10 年内死亡的患者(n=132)。
复发率为 16.3%,10 年总生存率为 38.6%,10 年无复发生存率为 16.7%。非病毒性、单发肿瘤、高分化和无严重纤维化是长期无复发生存的独立有利因素。高胆碱酯酶水平、肿瘤较小且无门静脉侵犯是复发患者长期生存的独立有利因素。复发后长期生存的患者早期复发、肝外复发和多发肝内复发明显较低。
HCC 患者长期预后的重要因素是单发肿瘤、肿瘤较小和无晚期纤维化。需要对非病毒性肝炎进行治疗以实现长期无复发生存。即使复发患者,如果存在晚期或单发肝内复发、非严重肝硬化和复发时的治愈性治疗,也可能长期生存。